Long-Term Survival and Gradual Recovery of B Cells in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel (Axi-Cel)
Year: 2020
Type: article
Source: Blood
Authors: Caron Jacobson, Frederick L. Locke, Armin Ghobadi, David B. Miklos, Lazaros J. Lekakis, Olalekan O. Oluwole, Yi Lin, Ira Braunschweig, Brian T. Hill, John M. Timmerman, Abhinav Deol, Patrick M. Reagan, Patrick J. Stiff, Ian W. Flinn, Umar Farooq, Andre H. Goy, Peter A. McSweeney, Javier Munoz, Tanya Siddiqi, John M. Rossi, Adrian Bot, Lianqing Zheng, Remus Vezan, Zahid Bashir, Jenny J. Kim, Rong Chu, Sattva S. Neelapu
Institutions: Harvard University, Dana-Farber Cancer Institute, Moffitt Cancer Center, Washington University in St. Louis, Stanford Medicine, Stanford University, University of Miami Health System, Sylvester Comprehensive Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Mayo Clinic, Albert Einstein College of Medicine, Montefiore Medical Center, Cleveland Clinic, University of California, Los Angeles, Wayne State University, The Barbara Ann Karmanos Cancer Institute, University of Rochester Medicine, University of Rochester, Loyola University Chicago, Sarah Cannon, Tennessee Oncology, University of Iowa, Hackensack University Medical Center, Colorado Blood Cancer Institute, Presbyterian St. Luke's Medical Center, Banner MD Anderson Cancer Center, City Of Hope National Medical Center, Kite (United States), The University of Texas MD Anderson Cancer Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3097517620